Four patients have so far received the treatment successfully in one eye and reported an improvement in their comfort and vision, and now await treatment in their other eye.
The University of Wisconsin is one of 15-20 research sites taking part in a Phase II study to "investigate the efficacy, tolerability, and safety of blood-derived selected stem cells to improve symptoms and clinical outcomes in patients with chronic myocardial ischemia (CMI), a severe form of coronary artery disease."
There's an event tonight at the University of Michigan co-sponsored by the Student Society for Stem Cell Research and the Students for Life focusing on embryonic stem cell research. I'm impressed these groups are working together to put on what looks to be an interesting and informative event. Each group has invited three speakers to address the issue. According the SFL web site, former congressman Joe Schwarz, Dr. Sue O'Shea and Kathleen Russell will be speaking for the SSSCR while Rep. Jack Hoogendyk, Dr. David Prentice and Cindy Northon will be speaking for the Students for Life.